The prevention and management of antiviral drug resistance remain central aspects of treatment strategies against infection with the hepatitis B virus (HBV). Whilst current therapeutic options for the de novo treatment of chronic hepatitis B (CHB) carry a low risk of...
CITATION STYLE
Beloukas, A., & Geretti, A. M. (2017). Hepatitis B Virus Drug Resistance. In Antimicrobial Drug Resistance (pp. 1227–1242). Springer International Publishing. https://doi.org/10.1007/978-3-319-47266-9_26
Mendeley helps you to discover research relevant for your work.